Aggregating Rs 200 crore
Suven Life Sciences announced that the QIP Committee (the "Committee") of the Board of Directors of the Company at its meeting held on 03 December 2014, has approved the allotment of 1,04,53,690 Equity shares of face value of Re. 1/- each at a premium of Rs. 190.32 per equity share aggregating to Rs. 200 crore.Powered by Capital Market - Live News